As the winter season intensifies the annual threat of respiratory syncytial virus (RSV) infections, the United States Human RSV Treatment Market is emerging as a critical frontier in public health and pharmaceutical innovation. According to a comprehensive analysis, the market is projected to expand significantly, driven by the escalating burden of RSV on vulnerable populations...